Header cover image

Israeli (TA) Drug Retail Industry Analysis

UpdatedJun 28, 2026
DataAggregated Company Financials
Companies1
  • 7D-2.8%
  • 3M-13.7%
  • 1Y12.1%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 2.8%, driven by pullbacks from every company within the industry. This takes the industry's 12 month performance to a gain of 15%.

Industry Valuation and Performance

Has the Israeli Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 28 Jun 2026₪290.0m₪78,000.00-₪5,200,000.00n/a-55.8x3718.3x
Tue, 26 May 2026₪329.1m₪78,000.00-₪5,200,000.00n/a-63.3x4219.3x
Thu, 23 Apr 2026₪257.4m₪78,000.00-₪5,085,000.00n/a-50.6x3300.5x
Sat, 21 Mar 2026₪277.4m₪78,000.00-₪5,085,000.00n/a-54.5x3556x
Mon, 16 Feb 2026₪264.3m₪84,000.00-₪5,307,000.00n/a-49.8x3146.5x
Wed, 14 Jan 2026₪267.9m₪84,000.00-₪5,307,000.00n/a-50.5x3189.2x
Fri, 12 Dec 2025₪170.1m₪84,000.00-₪5,307,000.00n/a-32.1x2025.4x
Wed, 13 Aug 2025₪174.3m₪116.0k-₪4,904,000.00n/a-35.5x1502.4x
Fri, 11 Jul 2025₪139.8m₪116.0k-₪4,904,000.00n/a-28.5x1205.3x
Sun, 08 Jun 2025₪116.7m₪116.0k-₪4,904,000.00n/a-23.8x1006x
Tue, 06 May 2025₪134.4m₪131.0k-₪5,023,000.00n/a-26.7x1025.7x
Thu, 03 Apr 2025₪130.9m₪131.0k-₪5,023,000.00n/a-26.1x999x
Sat, 01 Mar 2025₪149.6m₪142.0k-₪4,581,000.00n/a-32.7x1053.8x
Mon, 27 Jan 2025₪153.1m₪142.0k-₪4,581,000.00n/a-33.4x1078.3x
Wed, 25 Dec 2024₪155.3m₪142.0k-₪4,581,000.00n/a-33.9x1093.7x
Fri, 22 Nov 2024₪147.7m₪142.0k-₪4,581,000.00n/a-32.2x1039.9x
Sun, 20 Oct 2024₪143.7m₪142.0k-₪5,088,000.00n/a-28.2x1011.8x
Tue, 17 Sep 2024₪133.5m₪142.0k-₪5,088,000.00n/a-26.2x940x
Thu, 15 Aug 2024₪118.2m₪142.0k-₪5,932,000.00n/a-19.9x832.2x
Sat, 13 Jul 2024₪90.4m₪142.0k-₪5,932,000.00n/a-15.2x636.3x
Mon, 10 Jun 2024₪104.4m₪142.0k-₪5,932,000.00n/a-17.6x735x
Wed, 08 May 2024₪127.2m₪142.0k-₪5,932,000.00n/a-21.4x896x
Fri, 05 Apr 2024₪132.2m₪142.0k-₪5,932,000.00n/a-22.3x930.9x
Sun, 03 Mar 2024₪108.2m₪127.0k-₪15,596,000.00n/a-6.9x852.4x
Tue, 30 Jan 2024₪109.1m₪127.0k-₪15,596,000.00n/a-7x859.1x
Thu, 28 Dec 2023₪102.0m₪127.0k-₪15,596,000.00n/a-6.5x803.1x
Sat, 25 Nov 2023₪87.3m₪127.0k-₪15,596,000.00n/a-5.6x687.7x
Mon, 23 Oct 2023₪73.3m₪127.0k-₪15,596,000.00n/a-4.7x577.3x
Wed, 20 Sep 2023₪38.2m₪127.0k-₪15,596,000.00n/a-2.4x300.5x
Fri, 18 Aug 2023₪36.9m₪60,000.00-₪19,025,000.00n/a-1.9x614.5x
Sun, 16 Jul 2023₪43.3m₪60,000.00-₪19,025,000.00n/a-2.3x722.2x
Price to Earnings Ratio

-2.1x


Total Market Cap: ₪40.2mTotal Earnings: -₪19,025,000.00Total Revenue: ₪60,000.00Total Market Cap vs Earnings and Revenue0%0%0%
Israeli Drug Retail Industry Price to Earnings3Y Average -23.5x202420252026
Current Industry PE
    There is only one company in the Israeli Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have improved over the last three years.
  • Revenues for these companies have grown 9.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Israeli Drug Retail compare with similar industries?

IL Market-2.14%
Consumer Staples-2.75%
Food and Staples Retail-2.88%
Drug Retail-2.76%
Food Distributors-1.01%
Food Retail-3.32%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News